Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular Vesicles: New Classification and Tumor Immunosuppression. | Biology (Basel) | 2023 | 36671802 | PubTator, text mining | PubMed |
| O-Glycomic and Proteomic Signatures of Spontaneous and Butyrate-Stimulated Colorectal Cancer Cell Line Differentiation. | Mol Cell Proteomics | 2023 | 36669592 | PubTator, text mining | PubMed |
| The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. | Curr Oncol | 2023 | 36661697 | PubTator, text mining | PubMed |
| Sustained postconfluent culture of human mammary epithelial cells enriches for luminal and c-Kit+ subtypes. | Breast Cancer Res | 2023 | 36653787 | PubTator, text mining | PubMed |
| An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer. | Cancer Med | 2023 | 36629124 | PubTator, text mining | PubMed |
| A Cdh3-β-catenin-laminin signaling axis in a subset of breast tumor leader cells control leader cell polarization and directional collective migration. | Dev Cell | 2023 | 36626870 | PubTator, text mining | PubMed |
| Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer. | Mol Cancer Ther | 2023 | 36622760 | PubTator, text mining | PubMed |
| Comparative study of differentiating human pluripotent stem cells into vascular smooth muscle cells in hydrogel-based culture methods. | Regen Ther | 2023 | 36618488 | PubTator, text mining | PubMed |
| LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth. | Clin Cancer Res | 2023 | 36607777 | PubTator, text mining | PubMed |
| Mutation-associated transcripts reconstruct the prognostic features of oral tongue squamous cell carcinoma. | Int J Oral Sci | 2023 | 36593250 | PubTator, text mining | PubMed |
| Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis. | Ann Rheum Dis | 2023 | 36543524 | PubTator, text mining | PubMed |
Molecular mechanisms regulating wound repair: Evidence for paracrine signaling from corneal epithelial cells to fibroblasts and immune cells following transient epithelial cell treatment with Mitomycin C. | Exp Eye Res | 2023 | 36539051 | PubTator, text mining | PubMed |
| Genetic and phenotypic determinants of morphologies in 3D cultures and xenografts of lung tumor cell lines. | Cancer Sci | 2023 | 36533957 | PubTator, text mining | PubMed |
| Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. | Toxicol Sci | 2023 | 36519830 | PubTator, text mining | PubMed |
| Extracellular matrix in skin diseases: The road to new therapies. | J Adv Res | 2023 | 36481476 | PubTator, text mining | PubMed |
| Vascular smooth muscle cell senescence accelerates medin aggregation via small extracellular vesicle secretion and extracellular matrix reorganization. | Aging Cell | 2023 | 36433666 | PubTator, text mining | PubMed |
| Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma. | Oncologist | 2023 | 36427020 | PubTator, text mining | PubMed |
| Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives. | Cancer Commun (Lond) | 2023 | 36424360 | PubTator, text mining | PubMed |
| Overexpressed LAMC2 promotes trophoblast over-invasion through the PI3K/Akt/MMP2/9 pathway in placenta accreta spectrum. | J Obstet Gynaecol Res | 2023 | 36412218 | PubTator, text mining | PubMed |
| Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma. | Mol Oncol | 2023 | 36400567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=18